MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, TGTX made $161,709K in revenue. $390,895K in net income. Net profit margin of 241.73%.

Income Overview

Revenue
$161,709K
Net Income
$390,895K
Net Profit Margin
241.73%
EPS
$2.43
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • License

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2024-12-31
2024-09-30
Revenue
161,709 141,148 85,830 83,879
Cost of revenue
28,093 18,938 10,421 9,341
Noncash compensation
5,335 4,318 2,806 3,028
Other research and development
35,543 27,464 25,493 17,110
Total research and development
40,878 31,782 28,299 20,138
Noncash compensation
12,351 12,044 7,837 8,745
Other selling, general and administrative
51,022 43,541 28,934 33,221
Total selling, general and administrative
63,373 55,585 36,771 41,966
Total costs and expenses
132,344 106,305 --
Operating income
29,365 34,843 10,340 12,434
Interest expense
6,721 6,716 4,610 10,832
Other income
3,265 2,793 1,658 2,666
Total other expense, net
-3,456 -3,923 -2,952 -8,166
Net income before taxes
25,909 30,920 7,388 4,268
Income tax benefit (expense)
-364,986 2,733 1,076 388
Net income
390,895 28,187 6,312 3,880
Basic (in dollars per share)
2.69 0.19 0.04 0.03
Diluted (in dollars per share)
2.43 0.17 0.045 0.02
Us-gaap_weightedaveragenumberofdilutedsharesoutstanding
160,997,977 162,559,404 -79,900,954 160,714,388
Weighted-average common shares outstanding (in shares)
145,416,901 146,739,833 -72,256,271.5 145,102,479
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
License$2,392K Product$159,317K Revenue$161,709K Operating income$29,365K Total costs andexpenses$132,344K Income tax benefit(expense)-$364,986K Net income beforetaxes$25,909K Total other expense,net-$3,456K Other income$3,265K Total selling,general and...$63,373K Total research anddevelopment$40,878K Cost of revenue$28,093K Net income$390,895K Interest expense$6,721K Other selling,general and...$51,022K Noncash compensation$12,351K Other research anddevelopment$35,543K Noncash compensation$5,335K

TG Therapeutics BRIUMVI Approval Call Slide Deck 12

TG THERAPEUTICS, INC. (TGTX)

TG Therapeutics BRIUMVI Approval Call Slide Deck 12

TG THERAPEUTICS, INC. (TGTX)